MENU
+Compare
OMER
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$3.20
Change
-$0.12 (-3.61%)
Capitalization
186.32M

OMER Omeros Corp Forecast, Technical & Fundamental Analysis

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders... Show more

Industry: #Biotechnology
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OMER with price predictions
Jun 27, 2025

OMER sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for OMER moved below the 200-day moving average on May 23, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OMER as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OMER declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OMER broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for OMER entered a downward trend on June 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where OMER's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where OMER's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OMER just turned positive on June 02, 2025. Looking at past instances where OMER's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OMER advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.326). P/E Ratio (0.000) is within average values for comparable stocks, (58.407). OMER's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.310). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.768).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OMER’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OMER’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

OMER is expected to report earnings to fall 14.96% to -45 cents per share on August 06

Omeros Corp OMER Stock Earnings Reports
Q2'25
Est.
$-0.46
Q4'24
Beat
by $0.15
Q3'24
Beat
by $0.13
Q2'24
Missed
by $0.27
Q1'24
Missed
by $0.07
The last earnings report on March 31 showed earnings per share of -54 cents, beating the estimate of -68 cents. With 1.70M shares outstanding, the current market capitalization sits at 186.32M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
198
Web
https://www.omeros.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIGCX12.020.12
+1.01%
Victory RS International C
WFPDX12.630.10
+0.80%
Allspring Premier Large Co Gr Adm
CSGIX11.750.08
+0.69%
Calamos International Small Cap Gr I
IVGAX22.950.13
+0.57%
VY® Invesco Growth and Income A
TMPIX55.740.18
+0.32%
Touchstone Mid Cap Institutional

OMER and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OMER has been loosely correlated with VCYT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMER
1D Price
Change %
OMER100%
-3.61%
VCYT - OMER
40%
Loosely correlated
+2.13%
INM - OMER
36%
Loosely correlated
-2.31%
MDXG - OMER
36%
Loosely correlated
N/A
FULC - OMER
31%
Poorly correlated
-3.79%
ACIU - OMER
31%
Poorly correlated
-2.90%
More